UNSPSC 51201612: Mumps virus vaccine

This classification denotes a vaccine for an acute infectious disease caused by rubulavirus, spread by direct contact, airborne droplet nuclei, fomites contaminated by infectious saliva, and perhaps urine, and usually seen in children under the age of 15, although adults may also be affected.

UNSPSC 51201612 Mumps virus vaccine is a Commodity code that covers immunization biologics procured by state and local health agencies, though recent solicitation activity under this specific code shows limited volume. State and local health departments acquire vaccines through both competitive procurement and sole source designation when a single approved manufacturer exists or when public health urgency demands expedited access. The Mississippi State Department of Health, a repeat buyer of biologics through state procurement channels, issues notices for vaccine acquisition that trigger objection periods for alternative-source challenges under state procurement rules.

Recent activity under this code remains sparse. The Mississippi State Department of Health posted a sole source notice (3150006922, "1301-27-R-RFIN-00001") on July 13, 2026, for Yellow Fever Vaccine from Sanofi Pasteur, Inc., with an objection deadline of August 3, 2026 at 10:00 a.m. CST — the notice did not specify quantity, contract term, estimated value, or pricing. This posting falls under state procurement statutes that require health departments to publish sole source intent and allow interested parties to demonstrate alternative supplier availability; if substantiated objections are received, the department must conduct a competitive process or appeal to the state Public Procurement Review Board. No other recent opportunities appear in the record for this Commodity code, indicating either low procurement frequency, aggregation under broader vaccine or pharmaceutical codes, or use of cooperative purchasing vehicles that post at the state level rather than through individual health department solicitations.